We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+13.53%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$35.9B
AUM Growth
+$3.63B
Cap. Flow
+$30.8B
Cap. Flow %
85.82%
Top 10 Hldgs %
15.31%
Holding
2,049
New
1,918
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AAPL icon
Apple
AAPL
+$825M
3
NVDA icon
NVIDIA
NVDA
+$552M
4
TSM icon
TSMC
TSM
+$516M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$514M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Consumer Discretionary 14.69%
3 Healthcare 11.01%
4 Financials 9.76%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNQ icon
1801
Canadian Natural Resources
CNQ
$96.9B
$206K ﹤0.01%
+6,276
New +$203K
SVV icon
1802
Savers
SVV
$1.4B
$205K ﹤0.01%
+11,816
New +$179K
PRGS icon
1803
Progress Software
PRGS
$1.55B
$205K ﹤0.01%
+3,777
New +$200K
MYPS icon
1804
PLAYSTUDIOS Inc
MYPS
$79.3M
$204K ﹤0.01%
+75,238
New +$205K
BYND icon
1805
Beyond Meat
BYND
$288M
$203K ﹤0.01%
+22,797
New +$179K
AAN
1806
DELISTED
The Aaron's Company Inc
AAN
$202K ﹤0.01%
+18,565
New +$172K
PTEN icon
1807
Patterson-UTI
PTEN
$3.87B
$202K ﹤0.01%
+18,668
New +$227K
OOMA icon
1808
Ooma
OOMA
$550M
$200K ﹤0.01%
+18,600
New +$211K
LYRA
1809
DELISTED
LYRA THERAPEUTICS INC
LYRA
$199K ﹤0.01%
+760
New +$138K
NPCE icon
1810
Neuropace
NPCE
$505M
$199K ﹤0.01%
+19,298
New +$154K
NRIX icon
1811
Nurix Therapeutics
NRIX
$2.43B
$199K ﹤0.01%
+19,248
New +$132K
STEM icon
1812
Stem
STEM
$49.2M
$198K ﹤0.01%
+2,558
New +$176K
CLVT icon
1813
Clarivate
CLVT
$1.3B
$191K ﹤0.01%
+20,591
New +$152K
NIO icon
1814
NIO
NIO
$11.3B
$190K ﹤0.01%
+20,959
New +$166K
HNRG icon
1815
Hallador Energy
HNRG
$718M
$186K ﹤0.01%
+21,045
New +$265K
YEXT icon
1816
Yext
YEXT
$501M
$184K ﹤0.01%
+31,205
New +$192K
MCBC
1817
DELISTED
Macatawa Bank Corp
MCBC
$178K ﹤0.01%
+15,808
New +$155K
NMRK icon
1818
Newmark Group
NMRK
$2.73B
$177K ﹤0.01%
+16,114
New +$122K
EVC icon
1819
Entravision Communication
EVC
$983M
$176K ﹤0.01%
+42,300
New +$167K
INMB icon
1820
INmune Bio
INMB
$43.1M
$176K ﹤0.01%
+15,654
New +$131K
IREN icon
1821
Iris Energy
IREN
$13.2B
$176K ﹤0.01%
+24,569
New +$106K
GOGO icon
1822
Gogo Inc
GOGO
$515M
$173K ﹤0.01%
+17,100
New +$181K
CDXS icon
1823
Codexis
CDXS
$135M
$172K ﹤0.01%
+56,400
New +$121K
SONO icon
1824
Sonos
SONO
$1.75B
$172K ﹤0.01%
+10,006
New +$135K
INTT icon
1825
inTEST
INTT
$173M
$169K ﹤0.01%
+12,442
New +$165K

Similar funds

Man Group's Q4 2023 Portfolio in Review

As of Q4 2023, Man Group held 2,049 positions worth $35.9B, up 11% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Man Group deployed $30.8B of net new capital in Q4 2023, opening 1,918 new positions. Its largest new stake was Microsoft: 2,865,670 shares worth $1.08B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Man Group's largest Q4 2023 buy was Microsoft: 2,865,670 shares worth $1.08B.
  • Man Group's ten largest holdings make up 15% of its $35.9B portfolio in Q4 2023.
  • Man Group opened 1,918 new positions and closed 0 in Q4 2023.
  • Man Group's portfolio value rose 11% quarter-over-quarter to $35.9B.

Based on Man Group's 13F filing for Q4 2023, filed 14 Feb 2024.